As of 2026-08-21, Palisade Bio, Inc. Common Stock (PALI) has a 3-month relative strength percentile of 56 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 64. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.3%, relative volume 0.65×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
PALI appears in 1 ETF as of May 2026: AVSC at 0.01% weight, $171K notional.
Held by 3 ETFs · $3M across latest filings · largest weight 0.88% (SURI).
Top 1 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVSC | 0.01% | $171K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PALI Jan avg: -24.20% median: -27.09% win: 25% σ: 20.53% n: 4 2022-04-12 → 2026-07-31 | PALI Feb avg: -19.68% median: -29.23% win: 25% σ: 26.24% n: 4 2022-04-12 → 2026-07-31 | PALI Mar avg: 10.81% median: -0.93% win: 25% σ: 35.68% n: 4 2022-04-12 → 2026-07-31 | PALI Apr avg: -8.21% median: 0.73% win: 60% σ: 28.73% n: 5 2022-04-12 → 2026-07-31 | PALI May avg: -13.67% median: -16.98% win: 20% σ: 14.95% n: 5 2022-04-12 → 2026-07-31 | PALI Jun avg: -1.93% median: -6.64% win: 20% σ: 18.78% n: 5 2022-04-12 → 2026-07-31 | PALI Jul avg: 11.08% median: -5.32% win: 40% σ: 28.51% n: 5 2022-04-12 → 2026-07-31 | PALI Aug avg: -42.85% median: -45.81% win: 0% σ: 26.58% n: 4 2022-04-12 → 2026-07-31 (current) | PALI Sep avg: -6.51% median: -7.04% win: 50% σ: 27.82% n: 4 2022-04-12 → 2026-07-31 | PALI Oct avg: 26.20% median: -6.31% win: 25% σ: 76.83% n: 4 2022-04-12 → 2026-07-31 | PALI Nov avg: -2.40% median: -3.81% win: 50% σ: 12.17% n: 4 2022-04-12 → 2026-07-31 | PALI Dec avg: 1.63% median: 2.89% win: 50% σ: 28.10% n: 4 2022-04-12 → 2026-07-31 |